Treatment for Patients With Chronic Post-Concussion Symptoms
Cognitive Behavioral Treatment for Patients With Chronic Post-Concussion Symptoms
1 other identifier
interventional
40
1 country
1
Brief Summary
The current project will examine the effect of a brief psychological intervention on post-concussion symptoms, neurocognitive function, cerebral blood flow (CBF), and psychophysiological and salivary cortisol markers of autonomic nervous system (ANS) in a sample of 20 participants between 13-25 years of age who experience long-term post-concussive (PC) symptoms 2-9 months post-injury as well as 20 age- and sex-matched controls (non-injured) participants to provide normative data on all the above measures except for concussive symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedFirst Submitted
Initial submission to the registry
September 20, 2018
CompletedFirst Posted
Study publicly available on registry
November 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedOctober 29, 2021
October 1, 2021
4.7 years
September 20, 2018
October 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Self-Reported Symptoms After Treatment
Severity of self-reported symptoms on the Post-Concussion Symptom Inventory
baseline and 6 weeks
Change Self-Reported Quality of Life After Treatment
Self-reported scores on quality of life on Global Quality of Life Scale
baseline and 6 weeks
Secondary Outcomes (6)
Change in cerebral blood flow stress after treatment
baseline and 6 weeks
Change in peak salivary cortisol after treatment
baseline and 6 weeks
Change in respiration rate after treatment
baseline and 6 weeks
Change in end-tidal carbon dioxide after treatment
baseline and 6 weeks
Change in heart rate after treatment
baseline and 6 weeks
- +1 more secondary outcomes
Other Outcomes (9)
Change in depressive symptoms after treatment
baseline and 6 weeks
Change in anxiety symptoms after treatment
baseline and 6 weeks
Change in sleep quality after treatment
baseline and 6 weeks
- +6 more other outcomes
Study Arms (1)
Persistent Post-Concussion Symptoms
EXPERIMENTALConcussed participants with persistent post-concussion symptoms (PPCS) who receive the psychological intervention.
Interventions
Psychological treatment protocol designed to treat anxiety and avoidance in an adolescent/young adult population. The focus of treatment will be to address cognitive and behavioral factors associated with prolonged symptoms. Cognitive factors that may be addressed include, but are not limited to, catastrophizing, black or white thinking, and false expectations. Behavior factors that may be addressed include, but are not limited to, avoidance, relaxation, and behavioral activation. The psychological intervention is also designed to help reduce psychophysiological arousal associated with anxiety and stress. Participants will also be taught controlled shallow breathing exercises designed to normalize the ratio of sympathetic/parasympathetic activity.
Eligibility Criteria
You may qualify if:
- Between the ages of 13-25
- Diagnosed with a concussion or mild traumatic brain injury by a physician
- Currently experiencing post-concussive symptoms for at least two months after their injury but no longer than 9 months.
- Fluent English speaker
You may not qualify if:
- History of/or comorbid neurological conditions that might affect performance (including history of stroke, seizure disorder, moderate to severe traumatic brain injury, anoxia)
- Severe cardiovascular conditions.
- History of psychosis and current substance abuse or dependence.
- Current severe symptoms of depression and/or anxiety.
- \* No history of concussion in the past year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Los Angeles
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Asarnow, PhD
University of California, Los Angeles
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study Principal Investigator
Study Record Dates
First Submitted
September 20, 2018
First Posted
November 30, 2018
Study Start
June 1, 2018
Primary Completion
February 1, 2023
Study Completion
February 1, 2023
Last Updated
October 29, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 6 months following initial publication, lasting for 2 years after initial publication.
- Access Criteria
- Access to individual participant data will be considered for researchers with a graduate degree or above for post-hoc analyses or replication efforts. Applications to access individual participant data will be reviewed by principal investigator and appointed co-investigators.
All individual participant data that underlie results in a publication will be shared if requested by other researchers. These data will include Study Protocol, Statistical Analysis Plan, and Clinical Study Report. Data will be made available for sharing 6 months after publication and be available for a time frame of 2 years following initial publication. Access to IPD will be considered for researchers with a graduate degree or above for post-hoc analyses or replication efforts. Applications to access individual participant data will be reviewed by principal investigator and appointed co-investigators.